Search Results for: eteplirsen

Exondys 51 (eteplirsen)

Exondys 51 (eteplirsen), the first approved treatment designed to target the underlying cause of Duchenne muscular dystrophy (DMD), was approved by the FDA on Sept. 19, 2016. The drug is marketed ... Read more